Clinical Trial Update: A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety, efficacy, and pharmacokinetics of MegaLT Injection for treating refractory thrombocytopenia after radiotherapy, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• MegaLT Injection (MegaLT)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Refractory Thrombocytopenia | Phase 1 | Status: ACTIVE_NOT_RECRUITING